People: Catalyst Pharmaceutical Partners Inc (CPRX.OQ)

CPRX.OQ on NASDAQ Stock Exchange Capital Market

2.24USD
22 Jul 2014
Price Change (% chg)

$0.01 (+0.45%)
Prev Close
$2.23
Open
$2.23
Day's High
$2.28
Day's Low
$2.22
Volume
34,342
Avg. Vol
82,122
52-wk High
$3.63
52-wk Low
$1.07

Search Stocks

Winship, M. Douglas 

Brief Biography

Mr. M. Douglas Winship is the Vice President - Regulatory Operations of Catalyst Pharmaceutical Partners, Inc. Mr. Winship has worked in regulatory affairs in the healthcare industry for over 40 years. From 2004 to 2005, Mr. Winship was Vice President—Quality Assurance and Regulatory Affairs for Argos Therapeutics, Inc., a biotechnology company developing immunotherapy treatments for cancer, in Durham, North Carolina. Previously, Mr. Winship was employed by CEL-SCI Corp., a biotechnology company developing immune system based treatments, in Vienna, VA, from 1998 to 2002 as Senior Vice President—Regulatory Affairs and Quality Assurance, and from 1994 through 1998 as Vice President—Regulatory Affairs and Quality Assurance. From 1988 to 1994, Mr. Winship was employed by Curative Technologies, Inc., a health-care company involved in the wound-healing market, first as Director of Regulatory Affairs and Quality Assurance and later as Vice President of Regulatory Affairs and Quality Assurance. Mr. Winship earned his Bachelor of Science in chemistry from Upsala College.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
198,414 -- 60,015 258,429

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks